newsfilter
← Latest News
Business Wire·

Catabasis Pharmaceuticals Appoints Hugh M. Cole to its Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the appointment of Hugh M. Cole to its Board of Directors. Mr. Cole has more than 20 years of pharmaceutical business development experience and is currently the Chief Business Officer and Head of Corporate Development at Jounce Therapeutics.